Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer

Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, Chadwick L. Wright, Katharina Schregel, Susan Gillespie, Michael Berger, Andrea Camp, Jeffrey J. Chalmers, Priya Balasubramanian, Brandon L. Miller, Peter Amaya, Eleni Andreopoulou, Joseph Sparano, Charles L. Shapiro, Miguel Angel Villalona-Calero, Susan Geyer, Alice Chen, Michael R. Grever, Michael V Knopp, Bhuvaneswari Ramaswamy
doi: https://doi.org/10.1101/2020.01.20.20018218

Data Availability

All clinical trial data will be deposited in accordance with CTEP, NCI, and NIH guidelines.

Back to top
Posted January 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer
Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail Shoben, Meng Zhao, Ewa Mrozek, Rachel M. Layman, Erin Macrae, Wenrui Duan, Jun Zhang, Nathan Hall, Chadwick L. Wright, Katharina Schregel, Susan Gillespie, Michael Berger, Andrea Camp, Jeffrey J. Chalmers, Priya Balasubramanian, Brandon L. Miller, Peter Amaya, Eleni Andreopoulou, Joseph Sparano, Charles L. Shapiro, Miguel Angel Villalona-Calero, Susan Geyer, Alice Chen, Michael R. Grever, Michael V Knopp, Bhuvaneswari Ramaswamy
medRxiv 2020.01.20.20018218; doi: https://doi.org/10.1101/2020.01.20.20018218
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area